BAAM
TIL icon

Baker Avenue Asset Management’s Instil Bio TIL Stock Holding History

Baker Avenue Asset Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-200
Closed -$2.64K – 1761
2023
Q1 		$2.64K Buy
+200
New +$2.96K ﹤0.01% 948

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baker Avenue Asset Management's TIL Position: Q2 2023 in Review

Baker Avenue Asset Management sold out of Instil Bio (TIL) in Q2 2023, closing a stake of 200 shares — an estimated $2.64K sold.

Baker Avenue Asset Management first reported a position in TIL in Q1 2023 and held it in 1 quarter. The position peaked at $2.64K in Q1 2023. 62 funds tracked by Wall St. Rank hold TIL as of Q2 2023.

  • Baker Avenue Asset Management reported no remaining Instil Bio position as of Q2 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 200 Instil Bio shares in Q2 2023, an estimated $2.64K.
  • Baker Avenue Asset Management first reported a position in Instil Bio in Q1 2023 and held it in 1 quarter.
  • Baker Avenue Asset Management's Instil Bio position peaked at $2.64K in Q1 2023.
  • 62 funds tracked by Wall St. Rank held Instil Bio as of Q2 2023.

Based on Baker Avenue Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.